已收盤 07-18 16:00:00 美东时间
-0.330
-4.94%
美股大行评级 | 潜在涨幅40%!华兴资本首予Coinbase买入评级,目标价353.3!Sarepta治疗遭多家机构下调评级和目标价!
06-18 09:46
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1141651881139785729.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital:维持SurgePays Inc(SURG)"买入"评级,目标价从8.75美元升至9美元</p> <p>• Ascendiant Capital:维持LiqTech Internatio
06-17 09:46
B. Riley Securities analyst Anderson Schock initiates coverage on Inogen (NASDAQ:INGN) with a Buy rating and announces Price Target of $14.
06-17 01:31
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132593314765758464.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通:维持IDEAYA Biosciences(IDYA)"超配"评级,目标价从63美元升至66美元</p> <p>• Needham:上调Inogen(INGN)评级至"买入",目标价12美元</p> <p>• E
05-23 11:19
Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025.
05-23 01:38
Top Wall Street analysts changed their outlook on these top names. For a comple...
05-22 20:17
Needham analyst Mike Matson upgrades Inogen (NASDAQ:INGN) from Hold to Buy and announces $12 price target.
05-22 18:25
Stifel analyst Mathew Blackman maintains Inogen (NASDAQ:INGN) with a Hold and lowers the price target from $10 to $7.
05-08 21:56
Companies Reporting Before The Bell • Wallbox (NYSE:WBX) is estimated to report...
05-07 16:33
BOSTON, April 15, 2025 /PRNewswire/ -- Below is the March 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG). Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly U...
04-15 23:06